Chemspec Europe 2018 - The 33rd International Exhibition for Fine & Speciality Chemicals

Article

Sponsored Content

Chemspec Europe is a renowned market place for sourcing and trading of fine and speciality chemicals for a wide range of applications and industry sectors, including pharmaceuticals and bio-based chemicals.

 

With its combination of an international exhibition, a comprehensive conference programme, targeted networking events as well as a new Partnering Programme, Chemspec Europe 2018 offers visitors a unique opportunity to source products, find business partners and keep up-to-date with the latest findings in R&D.

 

The pharma conference themes at this year’s event include:

 

– The Pharma Panel on Outsourcing Best Practices will be of interest to a wide audience from Pharma, Crop Protection and Chemical companies, CROs and CMOs who are engaged in contract research and custom synthesis of Active Pharmaceutical Ingredients (API). The sessions will discuss approaches to developing global outsourcing strategies, identifying outsourcing partners, identifying approaches to mitigate risks, and addressing challenges associated with outsourcing and how to effectively manage partnerships.

 

– The Abou-Gharbia Lecture Theatre will focus on “Drug Discovery, Then and Now: The Road to Personalized Medicine” by Dr. Magid Abou-Gharbia, Moulder Center for Drug Discovery Research, School of pharmacy, Temple University, Philadelphia, PA, USA. The presentation will cover the themes “Discovery of Small Molecule Therapeutics”, “Companion Diagnostics and Targeted Therapies for Cancer” and “Precision Medicine’s Impact on Pharma and Health Care, Challenges and Future Opportunities.”

 

Contact Details:

Chemspec Europe 2018 - The 33rd International Exhibition for Fine & Speciality Chemicals
Date: 20th – 21st June 2018,
Venue: Koelnmesse, Cologne, Germany
Contact: info@chemspeceurope.com
URL: http://www.chemspeceurope.com/
Registration: https://chemspec.ticketstore-online.de/vrvisitor/?langid=EN

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Drug Digest: Focusing on Solid Dosage Trends and Demand
Behind the Headlines, episode 7
Related Content